Strategic partnerships Delve Health has a history of strategic collaborations with ActiGraph, AliveCor, UW Medicine, and ABM Respiratory Care, signaling strong openness to integrating external devices and data streams. This presents a sales opportunity to propose partnerships or co-development with wearable, EKG, and respiratory care providers to expand Digital Endpoints and remote monitoring capabilities.

Decentralized trial momentum The company emphasizes decentralized and hybrid trial models with a unified platform, Concierge-as-a-Service, and high ePRO/device compliance. This suggests potential upsell to sponsors seeking scalable, patient-centric remote monitoring, real-world evidence programs, or post-market studies that require robust patient engagement and data integrity.

Platform integrations Recent and ongoing integrations with AI video solutions, wearables, and healthcare tech partners indicate a readiness to expand data sources. A sales angle could target bio/pharma sponsors exploring richer data capture, better patient comprehension, and diverse digital endpoints through additional integrations or marketplace partnerships.

Clinical study reach With diverse therapeutic coverage (cardiology, oncology, CNS, dermatology, metabolic, rare diseases) and post-market study support, there is an opportunity to cross-sell to sponsors running multi-therapy or rare-disease trials that require long-term follow-up, adherence programs, and cross-site data harmonization.

Growth signals Revenue range and recent funding activity combined with a growing client roster imply early-stage but accelerating growth. A sales strategy could emphasize scalable, low-friction deployment of StudyPal with Concierge services to mid-market CROs and sponsors seeking faster trial startup, improved data quality, and reduced operational burden.